Underlays - Bio Magnetic Therapy News

Bio Magnetic Therapy News

Reportlinker Adds Proteomics - Technologies, Markets and Companies Tuesday, September 7, 2010 @ 10:53AMReportlinker.com announces that a new market research report is available in its catalogue:
Predicting how nanoparticles will react in the human body Sunday, August 15, 2010 @ 12:09PMResearchers at North Carolina State University have developed a method for predicting the ways nanoparticles will interact with biological systems - including the human body. Their work could have implications for improved human and environmental safety in the handling of nanomaterials, as well as applications for drug delivery.
Brain Tumor Imaging And Treatment Employing Iron Oxide Nanoparticles Wednesday, August 4, 2010 @ 5:22AMTiny particles of iron oxide could become tools for simultaneous tumor imaging and treatment, because of their magnetic properties and toxic effects against brain cancer cells. In mice, researchers from Emory University School of Medicine have demonstrated how these particles can deliver antibodies to implanted brain tumors, while enhancing tumor visibility via magnetic resonance imaging (MRI ...
European Research Project Aims to Improve the Diagnosis and Therapy of Brain Diseases Friday, July 30, 2010 @ 5:00AMThe partners in a new publicly-funded European research project today announced details of the multinational/multidisciplinary program: 'CSI: Central Nervous System Imaging.' This three-year ENIAC project aims to achieve substantial advances in state-of-the-art medical 3D-imaging platforms by focusing on the diagnosis and therapy of serious diseases of the central nervous system and brain.
Sucking the Ocean Through a Straw Monday, July 12, 2010 @ 4:45PM(PhysOrg.com) -- Scientists are reporting an advance toward the next big treatment revolution in dentistry - the era in which root canal therapy brings diseased teeth back to life, rather than leaving a `non-vital` or dead tooth in the mouth. In a report in the monthly journal ACS Nano: `Nanostructured Assemblies for Dental Application,` they describe a first-of-its-kind, nano-sized dental film ...
A new spin on drug delivery: Enhanced delivery of DNA payloads into cells Friday, July 9, 2010 @ 11:33AMChang Lu and his chemical engineering research group at Virginia Tech have discovered how to "greatly enhance" the delivery of DNA payloads into cells. The description of their work will be featured on the cover of Lab on a Chip (issue 16), the premier journal for researchers in microfluidics.
Gulf Coast Regional Center of Innovation and Commercialization and Houston Technology Center Announce Recipients of ... Friday, June 4, 2010 @ 7:47AMFour HTC Client Companies Eligible for $6.5M read more
Gulf Coast Regional Center of Innovation and Commercialization and Houston Technology Center Announce Recipients of ... Friday, June 4, 2010 @ 7:30AMThe Gulf Coast Regional Center of Innovation and Commercialization was pleased to announce four companies who will receive up to a total of $6.5 million in commercialization awards from the Texas Emerging Technology Fund . Â The announcement was made this morning at the Houston Technology Center , a business accelerator that assists Houston-based emerging technology companies, whose client ...
Autism Challenges American Science to Seek Cure Sunday, April 18, 2010 @ 6:30AM"Where America Stands" on Brain Disorder Diagnosed More Often Now Than in '90s
Autism Challenges American Science to Seek Cure Sunday, April 18, 2010 @ 6:30AMBrain Disorder Diagnosed More Often Now Than in 1990s
XOMA expands anti-inflammatory antibody intellectual property portfolio Tuesday, April 13, 2010 @ 5:16AMXOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that the U.S. Patent and Trademark Office has issued two new patents that significantly expand the company's intellectual property portfolio relating to its anti-inflammatory antibody, XOMA 052, that targets interleukin-1 beta (IL-1 beta).
2010 Translational Regenerative Medicine Forum to feature Bioheart's cell therapies for congestive heart failure Wednesday, March 31, 2010 @ 5:20AMBioheart, Inc., announced today that Dr. Karl E. Groth, the Company's Chairman and CEO will speak at the 2010 Translational Regenerative Medicine Forum in Winston-Salem, North Carolina, on April 8. Dr. Groth will discuss Bioheart's cell therapies for Congestive Heart Failure.
Study shows experimental thyroid drug reduces cholesterol Friday, March 12, 2010 @ 4:38AMAn experimental thyroid drug reduces cholesterol without the troublesome side effects experienced by some people on statins, according to a study published today in The New England Journal of Medicine. An international team of investigators at Johns Hopkins Medical Institutions, the Karolinska University Hospital and Institute, and The Feinstein Institute for Medical Research tested a substance ...
The Bemer experience – rest matters Thursday, March 11, 2010 @ 6:26AMI have long been able to understand the popularity of complementary medicine. This is despite the fact that I don’t understand how the therapies work (or purport to work) and have been told by many friendly scientists that alternative treatments make no sense at all.
March designated as 'National Autoimmune Diseases Awareness Month' Tuesday, March 9, 2010 @ 5:53AMOn the evening of March 4, 2010, the U.S. Senate passed a resolution designating March as "National Autoimmune Diseases Awareness Month" and supporting efforts to increase awareness of autoimmune diseases and increase funding for autoimmune disease research. The Senate resolution (S.RES.372) was introduced by Michigan Senator Carl Levin on December 8, 2009.
Interventional radiologists to highlight scientific advances, new discoveries at 35th Annual Scientific Meeting Thursday, February 25, 2010 @ 6:18AMInterventional radiologists-minimally invasive specialists-will share scientific advances and new discoveries in treating a host of diseases at the Society of Interventional Radiology's 35th Annual Scientific Meeting March 13ó¾ at the Tampa Convention Center, Tampa, Fla. This year's meeting theme is "IR Innovation"-one that celebrates the remarkable inventiveness of interventional radiologists.
MBL generates human monoclonal antibodies against pandemic A type influenza virus Wednesday, January 27, 2010 @ 4:08AMMedical & Biological Laboratories Co., Ltd. (MBL), with the collaboration of Osaka University, has successfully generated several fully human monoclonal antibodies against pandemic A (H1N1 and H3N2) type influenza virus by utilizing blood samples from volunteers who were inoculated with influenza vaccine.
Reportlinker Adds Nanotechnology in Medical Applications: The Global Market Monday, January 4, 2010 @ 8:15AMReportlinker.com announces that a new market research report is available in its catalogue:
From the Battlefields of Iraq Comes a New Weapon in the War Against Wrinkles; New Anti-Aging Protocol is Unique in ... Tuesday, November 10, 2009 @ 1:00AMMedical Science has stated that your body stops making the elastin protein responsible for the elasticity in your skin after 12 years old and that elastin diminishes with age and is irreversible. A study underwritten by the United States Department of Defense resulted in the first genetically engineered protein made from plant bio-technology that is believed to replace up to two years of lost ...
Prostate Cancer Screening: New Technology 300 Times More Sensitive Than Commercial Tests, Defines New PSA 'Zero' Tuesday, October 20, 2009 @ 10:23AMA team of Northwestern University researchers, using an extremely sensitive tool based on nanotechnology, has detected previously undetectable levels of prostate-specific antigen (PSA) in patients who have undergone radical prostatectomy.
In Brief: Exploring the limits of antiferromagnetism in nanostructured materials Friday, October 9, 2009 @ 12:38PM(PhysOrg.com) -- Researchers in the Electronic & Magnetic Materials & Devices Group (Argonne National Laboratory) and at Politecnico di Milano in Italy explored the limits of antiferromagnetism in a nanostructured material for the first time, measuring the temperature required to support antiferromagnetic order in atomic monolayers of manganese on tungsten as the dimensions of the structures are ...
Researchers engineer antidotes for blood-thinner aptamers Sunday, October 4, 2009 @ 11:08PMImagine a surgical patient on a blood-thinning drug who starts bleeding more than expected, and an antidote that works immediately - because the blood thinner and antidote were designed to work together. Researchers at Duke University Medical Center have engineered a way to do this for an entire, versatile class of drugs called aptamers and published their findings in Nature Medicine.
The ThermoDox and MR-HIFU program shows great promise for treating life-threatening cancers Wednesday, September 23, 2009 @ 8:25AMRoyal Philips Electronics (NYSE: PHG; AEX: PHI) and Celsion Corporation (NASDAQ: CLSN) today announced that their joint research program to evaluate ThermoDox® in combination with MR-HIFU (Magnetic Resonance guided High Intensity Focused Ultrasound) as a combination therapy to non-invasively treat difficult cancers has successfully completed the feasibility stage.
Researchers Use Golden Nanotubes For Imaging Agent To Detect Tumor Cells, Map Sentinel Lymph Node Monday, August 31, 2009 @ 12:01AMBiomedical researchers at the University of Arkansas for Medical Sciences in Little Rock have developed a special contrast-imaging agent that is capable of molecular mapping of lymphatic endothelial cells and detecting cancer metastasis in sentinel lymph nodes.
Denosumab reduces fracture risk in men receiving androgen-deprivation therapy for prostate cancer Tuesday, August 11, 2009 @ 6:07PMTwice-yearly treatment with denosumab, a new targeted therapy to stop bone loss, increased bone density and prevented spinal fractures in men receiving androgen-deprivation therapy for prostate cancer.
Microorganisms for imaging and/or treatment of tumors Tuesday, May 12, 2009 @ 4:50PMModified viruses encoding transporter proteins and methods for preparing the modified viruses are provided. Vaccines that contain the viruses are provided. The viruses also can be used in diagnostic methods, such detection and imaging
Nanotechnology holds promise for STD drug delivery Sunday, May 3, 2009 @ 4:41PMYale researchers describe a breakthrough in safe and effective administration of potential antiviral drugs - small interfering RNA (siRNA) molecules that silence genes - the first step in development of a new kind of treatment for sexually transmitted diseases (STDs). The work is reported May 4 as an advance online publication of Nature Materials.